Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine TAP block after abdominal surgery
ChiCTR2500114226Phase 4Not yet recruiting
- Sponsor
- Affiliated Qingdao Central Hospital of Qingdao University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (3 arms), sponsored by Affiliated Qingdao Central Hospital of Qingdao University. Primary endpoint: Pain Visual Analog Scale. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500114226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114226.